DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ advanced 2.96% to $2.09 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.25% to 19,681.75 and the Dow Jones Industrial Average rising 0.38% to 44,882.13.
The stock's rise snapped a two-day losing streak.
Inovio Pharmaceuticals Inc. closed 85.83% below its 52-week high of $14.75, which the company reached on April 1st.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 1.14% to $152.87, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 1.09% to $26.91.
Trading volume (657,041) remained 475,674 below its 50-day average volume of 1.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled January 30, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 30, 2025 17:27 ET (22:27 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。